This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time. ” To help communicate the new guidance, the PMCPA is planning to run two webinars next month for companies and media organisations, on 9 February and 21 February.
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels.
In a recent webinar from pharmaphorum, the National Institute for Health Research (NIHR) outlined why and how it has developed a new approach to engage with patients while complying with national regulations, such as those set out in the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice.
That was among the key messages from speakers at a joint European Forum for Good Clinical Practice (EFGCP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) webinar, held last week. This should cover the entire process, “starting with the writing, the review of the document, and its dissemination”.
In support of this goal, PQA has performed a review of its bylaws and proposes revisions which modernize and streamline this important governing document. If community pharmacists can easily collect these data, they can be an effective resource to promote clinical trial diversity. This webinar is supported by PQS.
Today, we published the 2024 PQA Annual Report, which documents our progress towards our strategic goals. PQA Quality Forum Webinar, on October 10, from 1-2 p.m. Members-Only Quality Forum Webinar, on November 21, sponsored by PQS by Innovaccer. 2024 PQA Leadership Summit, November 7-8 in Arlington, Va.
Helpful practitioner prescribing guidance is set forth in a simplified document here. We will release exciting details of our upcoming webinar addressing telemedicine soon. Stay tuned.
Offering Resources to Implement Point-of-Care Testing The National Community Pharmacists Association and National Alliance of State Pharmacy Associations have developed a new guidance document to help community pharmacy teams with their point-of-care testing services. "A prior to the PQA Leadership Summit.
This feedback was gathered via surveys and then further discussed by pilot participants during three collaborative webinars. For example, one participant described how varying levels of “urgency” could be communicated to pharmacists, empowering them to prioritize prescriptions for expedited review. Want to Learn More?
For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. laboratory notebooks, batch records, and technical reports) to submission documents (e.g., Accessed 7 September 2021.
and management communication strategy. In the years leading up to 2022, numerous publications were issued; networking events, webinars, and conferences were held; and regulatory panel discussions with regulators performed. Is the vendors’ documentation complete in order to assess GxP risks and GxP compliance?
Join our next Awesome Webinar Series with guest legal guru JD from Real Value Rx to answer any questions you have about the DSCSA delay. To be authorized: Pharmacies should ensure they receive, maintain, and update these documents as necessary to continue ordering from their ATP and be ready to provide copies of them upon request.
Whether it’s a new marketing technique, an efficient workflow process, or tips on managing inventory, sharing these with your peers can elevate the entire community. Encourage Open Communication: Create platforms where pharmacy owners can discuss challenges and share solutions. A great place to learn is our BLOG.
By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — As we recently blogged , FDA released three draft guidance documents to help enhance the predictability, consistency, and transparency of the 510(k) program. One of these documents focuses on “ Evidentiary Expectations for 510(k) Implant Devices.”
There are three main types of medical website content resources you can use for that: Webinars. Healthcare marketing apps can help marketers optimize their daily activities such as task organization, team communication, customer engagement, results tracking, and beyond. Master Modular Content Creation.
For example, going “paperless” and moving all of the documentation to the cloud and keeping only electronic documents from now on can be considered a part of digital transformation. Communication platforms (e.g., This often means switching from usual solutions to new, more advanced ones. Digital Content Factory ).
An important accompanying document for Joint Commission standards are Critical Access Hospital Accreditation Survey Activity Guide, for which the January 2023 guide can be found here. The latest antimicrobial stewardship regulations from The Joint Commission went into effect in January 2023.
In addition, several pieces of documentation will be required to support the API qualification, e.g. pharmacopeial compliance. It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation? It has proved to be most effective at high pH.
Lenz, Principal Medical Device Regulation Expert In early January, FDA released a draft guidance document titled Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations (Draft AI Guidance). By Adrienne R. User Interface Software Description Section VI.B
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content